L. Steiner

Animal Models for In Vivo Lactation Studies: Anatomy, Physiology and Milk Compositions in the Most Used Non-Clinical Species: A Contribution from the ConcePTION Project

D. Ventrella, M. Bacci, M. Forni, 2021, Animals : an open access journal from MDPI.

Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques

J. Brotchie, P. Ravenscroft, S. Fox, 2019, Movement disorders : official journal of the Movement Disorder Society.

Metoprolol‐pridopidine drug–drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease

P. Muglia, O. Spiegelstein, L. Rabinovich‐Guilatt, 2017, British journal of clinical pharmacology.

Therapeutic destruction of insulin receptor substrates for cancer treatment.

Alexander Levitzki, Meenhard Herlyn, Efrat Flashner-Abramson, 2013, Cancer research.

ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.

A. Levitzki, G. Blum, Y. Friedmann, 2007, European journal of pharmacology.

Directly Compressed Tablets: A Novel Drug‐Containing Reservoir Combined with Hydrogel‐Forming Microneedle Arrays for Transdermal Drug Delivery

H. McCarthy, Galit Levin, R. Donnelly, 2020, Advanced healthcare materials.

Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery

Maelíosa T. C. McCrudden, H. McCarthy, Galit Levin, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

M. Geva, M. Cenci, V. Francardo, 2019, Neurotherapeutics.

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease

M. Hayden, M. Geva, M. Cenci, 2019, Neurotherapeutics.

Therapeutic destruction of insulin receptor substrates for cancer treatment.

M. Herlyn, A. Levitzki, M. Bar‐eli, 2013, Cancer research.